Pharmacists Play a Crucial Role in Adalimumab Biosimilars for Patient Care
Pharmacy Times
MARCH 5, 2025
Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.
Pharmacy Times
MARCH 5, 2025
Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.
The Checkup by Singlecare
MAY 8, 2024
Healthcare providers call upon Remicade for patient care if they fall into the moderate to severe categories. Remicade dosages for ulcerative colitis Dosages of Remicade are established for the induction and maintenance of disease remission. Some people like the fact that Remicade isn’t a self-injection.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
NOVEMBER 29, 2022
In addition, the guideline has been misapplied to cancer and palliative care patients, and there have been rapid opioid tapers without patient collaboration, rigid application of opioid dosage thresholds, application of opioid use for pain to opioid use disorder treatment, insurer and pharmacy duration limits, patient dismissals and abandonment.
IDStewardship
JUNE 6, 2023
Patient Education and Adherence : AI chatbots or virtual assistants can be developed to provide patients with on-demand information about their medications, dosages, potential side effects, and adherence strategies. This empowers patients to make informed decisions and fosters better medication adherence.
Board Vitals - Pharmacist
JANUARY 11, 2024
January 12th is National Pharmacist Day, when we recognize the contribution that pharmacists have made–and continue to make–to patient care and our healthcare systems. Each year, patients fill hundreds of millions of prescriptions, keeping pharmacists busier than ever.
The Checkup by Singlecare
JULY 17, 2024
3 ways to use AI to help patients Let’s explore how pharmacists can use AI services to help patients. Streamlining workflow AI can automate certain aspects of pharmacy workflow, allowing pharmacists to focus more on patient care. One way in which AI models can help is through inventory management.
European Pharmaceutical Review
JANUARY 8, 2025
Results also showed that over fifty percent of patients (66 percent) reported reduced pain and itching scores. Therefore, interim results from the Phase IIa study are a significant milestone, underscoring HT-001’s potential to transform patient care by mitigating debilitating skin toxicities while maintaining critical cancer treatments.
Let's personalize your content